Specialized pro-resolving receptors are expressed in salivary glands with Sjögren's syndrome.


Journal

Annals of diagnostic pathology
ISSN: 1532-8198
Titre abrégé: Ann Diagn Pathol
Pays: United States
ID NLM: 9800503

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 05 10 2021
revised: 27 10 2021
accepted: 11 11 2021
pubmed: 1 12 2021
medline: 23 3 2022
entrez: 30 11 2021
Statut: ppublish

Résumé

Our previous studies demonstrated that resolvin D1 (RvD1) and its aspirin-trigged (AT) form AT-RvD1, are effective in decreasing inflammation while restoring saliva flow rates in a Sjögren's syndrome (SS)-like mouse model before and after disease onset. Resolvins are specialized pro-resolving mediators (SPM) that actively regulate inflammation. However, we only have extensive data within the salivary glands for RvD1 and AT-RvD1, both of which bind to the receptor ALX/FPR2. As such, the presence of other SPM receptors is unknown within salivary glands. Therefore, the goal of this study was to determine the expression of SPM receptors in non-SS and SS patients. For this purpose, six human minor salivary glands from female subjects were analyzed by H&E using the Chisholm and Mason classification to determine the degree of lymphocytic infiltration. Next, confocal immunofluorescence analysis was performed to determine the presence and distribution of different SPM receptors in mucous acini and striated ducts. We observed diffuse presence of lymphocytic infiltration and clinical data were consistent with SS diagnosis in three patients. Moreover, confocal immunofluorescence analysis indicated the presence of the receptors ALX/FPR2, BLT1 and CMKLR1 in the mucous acini and striated ducts of both non-SS and SS patients. GPR32 was absent in SS and non-SS minor salivary glands. In summary, our results showed that various SPM receptors are expressed in non-SS and SS minor salivary glands, all of which may pose as potential targets for promoting pro-epithelial and anti-inflammatory/pro-resolution signaling on SS patients.

Identifiants

pubmed: 34847389
pii: S1092-9134(21)00165-9
doi: 10.1016/j.anndiagpath.2021.151865
pmc: PMC8938998
mid: NIHMS1788319
pii:
doi:

Substances chimiques

CMKLR1 protein, human 0
FPR2 protein, human 0
GPR32 protein, human 0
LTB4R protein, human 0
Receptors, Chemokine 0
Receptors, Formyl Peptide 0
Receptors, G-Protein-Coupled 0
Receptors, Leukotriene B4 0
Receptors, Lipoxin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151865

Subventions

Organisme : NIDCR NIH HHS
ID : R01 DE027884
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

Int J Mol Sci. 2013 Mar 08;14(3):5501-18
pubmed: 23528855
J Autoimmun. 2019 Nov;104:102315
pubmed: 31421964
Front Pharmacol. 2018 Nov 14;9:1273
pubmed: 30487747
Clin Exp Rheumatol. 2016 Mar-Apr;34(2):161-71
pubmed: 27095672
Curr Rheumatol Rep. 2011 Dec;13(6):482-8
pubmed: 21870104
Nature. 2014 Jun 5;510(7503):92-101
pubmed: 24899309
Scand J Immunol. 2004 Jun;59(6):592-9
pubmed: 15182255
J Exp Med. 2005 Mar 7;201(5):713-22
pubmed: 15753205
Clin Exp Rheumatol. 2015 Jan-Feb;33(1):56-62
pubmed: 25535773
Eur J Pharmacol. 2016 Aug 15;785:144-155
pubmed: 26546247
Health Qual Life Outcomes. 2009 May 27;7:46
pubmed: 19473510
J Autoimmun. 2019 Nov;104:102335
pubmed: 31540861
Sci Adv. 2021 Apr 2;7(14):
pubmed: 33811066
Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):114-122
pubmed: 31464670
J Biol Chem. 2006 Aug 11;281(32):22847-54
pubmed: 16757471
Ann Rheum Dis. 2014 Aug;73(8):1537-40
pubmed: 24525912
Sci Rep. 2017 Dec 14;7(1):17571
pubmed: 29242559
Adv Immunol. 1989;44:93-151
pubmed: 2646863
J Leukoc Biol. 2010 Feb;87(2):323-32
pubmed: 19880577
Mol Aspects Med. 2017 Dec;58:1-11
pubmed: 28263773
Vestn Oftalmol. 2019;135(5. Vyp. 2):192-198
pubmed: 31691659
Chem Biol. 2013 Feb 21;20(2):188-201
pubmed: 23438748
Inflamm Res. 2016 Aug;65(8):635-45
pubmed: 27056390
Arthritis Rheum. 2011 Oct;63(10):3103-15
pubmed: 21618203
J Clin Lab Immunol. 1992 Jan;37(1):39-49
pubmed: 1339235
J Clin Lab Anal. 1993;7(3):180-7
pubmed: 8509947
Int J Pharm. 2010 Jan 4;383(1-2):99-105
pubmed: 19747964
Methods Mol Biol. 2018;1845:17-30
pubmed: 30141005
J Dent Res. 2014 Mar;93(3):300-5
pubmed: 24389810
Physiol Rep. 2016 Oct;4(19):
pubmed: 27694530
Int J Mol Sci. 2018 Jun 19;19(6):
pubmed: 29921749
Clin Exp Rheumatol. 2001 Jul-Aug;19(4):411-5
pubmed: 11491496
Med Hypotheses. 2008 Aug;71(2):237-40
pubmed: 18448265
Sci Rep. 2018 Dec 21;8(1):18050
pubmed: 30575798
Br J Pharmacol. 2008 Mar;153 Suppl 1:S200-15
pubmed: 17965751
J Immunol. 1994 Jun 1;152(11):5532-9
pubmed: 8189070
FASEB J. 2017 Apr;31(4):1273-1288
pubmed: 28087575
Sci Adv. 2019 Oct 23;5(10):eaax4895
pubmed: 31681846
Nat Rev Rheumatol. 2013 Sep;9(9):544-56
pubmed: 23857130
Am J Physiol Cell Physiol. 2014 Jan 15;306(2):C178-85
pubmed: 24259417
Front Pharmacol. 2019 Jan 17;9:1582
pubmed: 30705632
Ann Rheum Dis. 2014 Jan;73(1):1-2
pubmed: 24092418
Oral Dis. 2017 Jul;23(5):576-597
pubmed: 27426637
Prostaglandins Leukot Essent Fatty Acids. 2008 Sep-Nov;79(3-5):157-63
pubmed: 19008087
Prostaglandins Leukot Essent Fatty Acids. 2017 Feb;117:17-27
pubmed: 28237084
Eur J Pharmacol. 1994 Jan 3;270(1):45-51
pubmed: 7512508
Rapid Commun Mass Spectrom. 2008;22(2):75-83
pubmed: 18059001
Rheum Dis Clin North Am. 2016 Aug;42(3):435-47
pubmed: 27431346
Reumatol Clin. 2015 Nov-Dec;11(6):387-94
pubmed: 26022574
J Periodontol. 2009 Mar;80(3):429-35
pubmed: 19254127
HNO. 2009 Sep;57(9):959-63
pubmed: 19696974
JAMA. 2010 Jul 28;304(4):452-60
pubmed: 20664046
Oral Dis. 2019 Jul;25(5):1265-1276
pubmed: 30230662
PLoS One. 2007 Dec 19;2(12):e1316
pubmed: 18091990
Lab Invest. 2013 Sep;93(9):991-1000
pubmed: 23857007
Nat Clin Pract Rheumatol. 2007 Oct;3(10):570-9; quiz 1 p following 589
pubmed: 17906612
Mucosal Immunol. 2013 Mar;6(2):256-66
pubmed: 22785226
Lab Invest. 2018 Jan;98(1):130-140
pubmed: 29083412
Nat Commun. 2018 Jan 4;9(1):59
pubmed: 29302056
Scand J Immunol. 2004 Dec;60(6):552-65
pubmed: 15584966
Nat Med. 2015 Sep;21(9):1071-5
pubmed: 26236990
Clin Transl Sci. 2021 Mar;14(2):683-691
pubmed: 33202089
J Clin Pathol. 1968 Sep;21(5):656-60
pubmed: 5697370
Semin Arthritis Rheum. 1995 Oct;25(2):117-33
pubmed: 8578312
Clin Exp Dent Res. 2020 Apr;6(2):225-235
pubmed: 32250566
Oral Dis. 2002 May;8(3):130-40
pubmed: 12108757
JCI Insight. 2018 Mar 22;3(6):
pubmed: 29563331
J Child Neurol. 1999 Sep;14(9):583-90; discussion 590-1
pubmed: 10488903
Cold Spring Harb Perspect Biol. 2014 Oct 30;7(2):a016311
pubmed: 25359497
Indian J Pathol Microbiol. 2011 Apr-Jun;54(2):430-1
pubmed: 21623127
Mol Aspects Med. 2017 Dec;58:114-129
pubmed: 28336292
Sci Rep. 2018 Aug 8;8(1):11873
pubmed: 30089836
Autoimmun Rev. 2010 Nov;10(1):38-42
pubmed: 20817127
Am J Physiol Cell Physiol. 2012 Apr 1;302(7):C968-78
pubmed: 22205391
Kurume Med J. 2009;56(3-4):39-47
pubmed: 20505281
FASEB J. 2018 Jul;32(7):4043-4052
pubmed: 29490167
Sci Rep. 2016 Apr 11;6:24244
pubmed: 27064029
J Immunol. 2005 Apr 1;174(7):4345-55
pubmed: 15778399
Sci Transl Med. 2016 Aug 24;8(353):353ra111
pubmed: 27559094
Trends Immunol. 2007 Apr;28(4):176-83
pubmed: 17337246
Lancet. 2005 Jul 23-29;366(9482):321-31
pubmed: 16039337
Eur J Oral Sci. 2005 Apr;113(2):101-13
pubmed: 15819815
J Biol Chem. 2007 Mar 30;282(13):9323-9334
pubmed: 17244615
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Jan;97(1):28-46
pubmed: 14716254
Am J Pathol. 2018 Jul;188(7):1555-1562
pubmed: 29684359
J Rheum Dis Treat. 2015;1(4):
pubmed: 27110599
Mucosal Immunol. 2016 May;9(3):757-766
pubmed: 26462421
Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii3-4
pubmed: 16987829
Crit Rev Oral Biol Med. 1993;4(5):639-77
pubmed: 8292713
J Clin Invest. 2018 Jul 2;128(7):2657-2669
pubmed: 29757195
Oxid Med Cell Longev. 2013;2013:185715
pubmed: 24381712
J Autoimmun. 2020 Jun;110:102364
pubmed: 31831255
J Immunol. 2012 Jul 15;189(2):1036-42
pubmed: 22711890
Ann Rheum Dis. 2002 Jun;61(6):554-8
pubmed: 12006334
Clin Exp Rheumatol. 2015 Mar-Apr;33(2):259-71
pubmed: 25896475
J Immunol. 2006 Nov 1;177(9):5902-11
pubmed: 17056514
Cell Metab. 2014 Jan 7;19(1):21-36
pubmed: 24239568
Sci Rep. 2017 Mar 31;7:45525
pubmed: 28361884
Clin Immunol. 2017 Sep;182:41-47
pubmed: 28476436
J Otolaryngol. 1997 Oct;26(5):300-5
pubmed: 9343767
Aust N Z J Med. 1992 Dec;22(6):671-8
pubmed: 1336955
Aust Dent J. 2013 Mar;58(1):11-7
pubmed: 23441787
Ear Nose Throat J. 2011 Oct;90(10):E20-2
pubmed: 22033967
J Exp Med. 2018 Jan 2;215(1):115-140
pubmed: 29191914
Annu Rev Pathol. 2014;9:273-85
pubmed: 24050623
Prostaglandins Other Lipid Mediat. 2017 Nov;133:103-110
pubmed: 28602942
Crit Care Med. 2015 Dec;43(12):2642-50
pubmed: 26488221
FASEB J. 2016 Aug;30(8):2792-801
pubmed: 27121596
Arch Med Res. 2006 Nov;37(8):921-32
pubmed: 17045106
Front Immunol. 2019 Sep 03;10:2095
pubmed: 31552041
Oral Surg Oral Med Oral Pathol. 1975 Jun;39(6):875-85
pubmed: 1055974
Rheum Dis Clin North Am. 2008 Nov;34(4):833-45, vii
pubmed: 18984407
Med Oral Patol Oral Cir Bucal. 2009 Jan 01;14(1):E8-E11
pubmed: 19114958
Acta Biomater. 2017 Apr 15;53:109-122
pubmed: 28213094
Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4743-52
pubmed: 19407006
Int J Dent Hyg. 2009 May;7(2):126-30
pubmed: 19416095
Rheumatology (Oxford). 2005 Aug;44(8):965-70
pubmed: 15840601
J Autoimmun. 2012 Aug;39(1-2):9-14
pubmed: 22209352
Autoimmunity. 1992;12(3):185-91
pubmed: 1343766
FASEB J. 2014 Jul;28(7):3090-102
pubmed: 24692596
Oral Dis. 2014 Mar;20(2):153-61
pubmed: 23557026
Am J Physiol Cell Physiol. 2012 May 1;302(9):C1331-45
pubmed: 22237406
Scand J Rheumatol Suppl. 2002;116:3-13
pubmed: 12109541
Trends Neurosci. 2011 Nov;34(11):599-609
pubmed: 21963090
Haematologica. 2020 Aug;105(8):2056-2070
pubmed: 31780628
Rheumatology (Oxford). 2019 Jul 1;58(7):1285-1292
pubmed: 30877775
J Periodontol. 2008 Aug;79(8 Suppl):1520-6
pubmed: 18673006
Rheum Dis Clin North Am. 1992 Aug;18(3):517-38
pubmed: 1323135
Respirol Case Rep. 2017 Dec 22;6(2):e00285
pubmed: 29321929
Annu Rev Pathol. 2008;3:279-312
pubmed: 18233953
Prostaglandins Leukot Essent Fatty Acids. 2018 Nov;138:81-89
pubmed: 26858146

Auteurs

Harim Tavares Dos Santos (HT)

Department of Otolaryngology-Head and Neck Surgery, University of Missouri, Columbia, MO, USA; Department of Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.

Kihoon Nam (K)

Department of Otolaryngology-Head and Neck Surgery, University of Missouri, Columbia, MO, USA; Department of Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.

Frank Maslow (F)

Department of Otolaryngology-Head and Neck Surgery, University of Missouri, Columbia, MO, USA; Department of Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.

Bryan Trump (B)

School of Dentistry and Department of Dermatology, University of Utah, Salt Lake City, UT, USA.

Olga J Baker (OJ)

Department of Otolaryngology-Head and Neck Surgery, University of Missouri, Columbia, MO, USA; Department of Biochemistry, University of Missouri, Columbia, MO, USA; Department of Bond Life Sciences Center, University of Missouri, Columbia, MO, USA. Electronic address: bakero@health.missouri.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH